Literature DB >> 11826333

A randomized survey of the preference of gastroenterologists for a Cochrane review versus a traditional narrative review.

John W D McDonald1, Jeffrey Mahon, Kelly Zarnke, Brian Feagan, Lorinda Simms, Wayne Tucker.   

Abstract

BACKGROUND: Clinicians often rely on review material rather than analysis of primary research to guide therapy. Systematic reviews use methods to insure thoroughness and to minimize bias, but many clinicians are not familiar with systematic reviews and continue to rely on narrative reviews.
OBJECTIVES: To determine whether a traditional narrative review or a systematic review is perceived to be more useful.
METHODS: A clinical scenario (patient with chronic Crohn's disease considered for azathioprine therapy) was circulated to gastroenterologists, along with a narrative review of therapy (including azathioprine) for inflammatory bowel disease written by an acknowledged expert, or with a systematic Cochrane review of the use of azathioprine for this disease. Whether knowledge of authorship and journal source influences the perception of usefulness of a narrative review was investigated.
RESULTS: The Cochrane review was rated significantly more highly than the narrative review on a 100 mm visual analogue scale (21.3 mm; 95% CI 14.5 to 28 mm). The proportion of respondents who considered the review to be a useful guide was also higher in the group that received the Cochrane review (91%) than in the group that received the narrative review, with author and journal concealed (62%) or identified (70%) (P<0.001 for both comparisons). Ratings from the two groups that received the narrative review were not significantly different.
CONCLUSIONS: The focused systematic review was perceived to be more useful than a traditional broad narrative review as a guide to making a decision concerning the use of specific therapy. The possible strengths of systematic reviews should be more fully investigated. If there is additional evidence supporting their greater value to clinicians, they should be made more widely available to clinicians and their strengths should be publicized.

Entities:  

Mesh:

Year:  2002        PMID: 11826333     DOI: 10.1155/2002/513758

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  3 in total

Review 1.  Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study.

Authors:  Veronica Yank; Drummond Rennie; Lisa A Bero
Journal:  BMJ       Date:  2007-11-16

2.  Impact of pharmaceutical industry versus university sponsorship on survey response: a randomized trial among Canadian hepatitis C care providers.

Authors:  Robert P Myers; Abdel Aziz M Shaheen; Samuel S Lee
Journal:  Can J Gastroenterol       Date:  2007-03       Impact factor: 3.522

3.  Using a systematic review in clinical decision making: a pilot parallel, randomized controlled trial.

Authors:  Laure Perrier; Nav Persaud; Kevin E Thorpe; Sharon E Straus
Journal:  Implement Sci       Date:  2015-08-15       Impact factor: 7.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.